Insider Stock Trading History of Paul Steven M


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Paul Steven M since year 2005. The trader's CIK number is 1237564. At the time of this reporting, Paul Steven M is the President and CEO of Voyager Therapeutics, Inc. . (stock ticker symbol VYGR). See this page for all insider trading activities at Voyager Therapeutics, Inc. .

Note that in the past PAUL STEVEN M also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Paul Steven M since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-01-14 VYGR Voyager Therapeutics, Inc. Buy 10,000 14.07 140,690
2015-09-01 SAGE Sage Therapeutics, Inc. Sale 20,000 52.40 1,047,900
2015-08-03 SAGE Sage Therapeutics, Inc. Sale 20,000 67.15 1,343,000
2015-07-01 SAGE Sage Therapeutics, Inc. Sale 20,000 69.82 1,396,300
2015-06-01 SAGE Sage Therapeutics, Inc. Sale 20,000 72.65 1,453,020
2015-05-01 BFAM Sage Therapeutics, Inc. Sale 20,000 53.31 1,066,200
2015-04-01 SAGE Sage Therapeutics, Inc. Sale 20,000 48.51 970,200
2015-01-26 ALNY Alnylam Pharmaceuticals, Inc. Buy 1,000 95.00 95,000
2015-01-02 SIAL Sigma Aldrich Corp Option Ex 684 .00 0
2014-07-23 SAGE Sage Therapeutics, Inc. Buy 10,000 18.00 180,000
2014-01-02 SIAL Sigma Aldrich Corp Option Ex 373 .00 0
2010-02-01 LLY Co Option Ex 51,249 .00 0
2008-02-04 LLY Co Sale 19,822 51.58 1,022,458
2007-05-21 LLY Co Option Ex 98,008 54.80 5,370,838
2007-05-15 LLY Co Option Ex 1,992 54.80 109,161
2007-03-12 LLY Co Sale 7,289 52.39 381,870
2007-02-12 LLY Co Sale 7,290 54.38 396,430
2007-02-08 LLY Co Sale 10,092 54.32 548,247
2006-10-20 LLY Co Sale 4,836 56.91 275,216
2006-09-15 LLY Co Option Ex 2,890 34.60 99,979
2006-04-21 LLY Co Sale 25,000 52.80 1,320,000
2006-02-02 LLY Co Sale 6,201 57.00 353,457

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Paul Steven M (President and CEO of Voyager Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.